Approved Therapy, Ibrance, Seen to Block Metastasis in Triple Negative Breast Cancer Study
News
Researchers may be one step closer to preventing triple-negative breast cancer, the most aggressive subtype of breast cancer, from spreading elsewhere in a person. Ibrance (palbociclib), an FDA-approved drug ... Read more